SOPHiA GENETICS SA
SOPH- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- SEC CIK
- 0001840706
In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 35 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding SOPHiA GENETICS SA changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 36 | +5 |
| Shares | 16.9M | 250 | 17.2M | +304.5K (+1.8%) |
| Value | $43.2M | $636 | $81.2M | +$38.0M (+88.1%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held SOPHiA GENETICS SA at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 199,997 | $942.0K | 0.13% |
| Essex Investment Management Co LLC | 123,901 | $583.6K | 0.11% |
| Legato Capital Management LLC | 49,899 | $235.0K | 0.03% |
| Schonfeld Strategic Advisors LLC | 40,200 | $189.3K | 0.00% |
| Royal Bank of Canada | 600 | $3.00K | 0.00% |
| Principal Securities, Inc. | 173 | $815 | 0.00% |
Sold out (1)
Institutions that held SOPHiA GENETICS SA at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Balyasny Asset Management LLC | 48,277 | $123.1K |
Not filed for Q4 2023 yet (1)
Institutions that held SOPHiA GENETICS SA at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Column Capital Advisors, LLC | 250 | $636 |